Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Cash Flow Reinvestment Rate
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥30.01 Million (capex CN¥30.01 Million ) from operating cash flow of CN¥130.05 Million. See how much free cash does Zhejiang Xianju Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Zhejiang Xianju Pharmaceutical Co Ltd (002332) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Zhejiang Xianju Pharmaceutical Co Ltd. See Zhejiang Xianju Pharmaceutical Co Ltd (002332) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥210.78 Million | CN¥247.48 Million | CN¥209.07 Million | ▲ +49.1% |
| 2024 | 0.57x | CN¥227.68 Million | CN¥398.66 Million | CN¥207.59 Million | ▼ -21.1% |
| 2023 | 0.72x | CN¥431.26 Million | CN¥595.48 Million | CN¥234.63 Million | ▼ -31.1% |
| 2022 | 1.05x | CN¥640.61 Million | CN¥609.28 Million | CN¥282.54 Million | ▲ +160.0% |
| 2021 | 0.40x | CN¥273.38 Million | CN¥676.15 Million | CN¥266.84 Million | ▼ -46.5% |
| 2020 | 0.76x | CN¥596.55 Million | CN¥789.23 Million | CN¥118.17 Million | ▲ +32.7% |
| 2019 | 0.57x | CN¥296.18 Million | CN¥519.81 Million | CN¥262.34 Million | ▼ -61.7% |
| 2018 | 1.49x | CN¥287.70 Million | CN¥193.27 Million | CN¥169.26 Million | ▼ -1.5% |
| 2017 | 1.51x | CN¥253.16 Million | CN¥167.47 Million | CN¥123.28 Million | ▲ +77.1% |
| 2016 | 0.85x | CN¥133.11 Million | CN¥155.91 Million | CN¥97.10 Million | ▼ -65.9% |
| 2015 | 2.50x | CN¥499.17 Million | CN¥199.61 Million | CN¥115.05 Million | ▲ +227.2% |
| 2014 | 0.76x | CN¥108.26 Million | CN¥141.64 Million | CN¥108.26 Million | ▼ -74.4% |
| 2013 | 2.98x | CN¥189.26 Million | CN¥63.46 Million | CN¥189.26 Million | ▼ -66.5% |
| 2012 | 8.91x | CN¥298.01 Million | CN¥33.43 Million | CN¥298.01 Million | ▲ +380.1% |
| 2011 | 1.86x | CN¥274.14 Million | CN¥147.63 Million | CN¥274.14 Million | ▲ +360.8% |
| 2010 | 0.40x | CN¥62.58 Million | CN¥155.29 Million | CN¥62.58 Million | ▼ -1.8% |
| 2009 | 0.41x | CN¥42.94 Million | CN¥104.68 Million | CN¥42.94 Million | ▼ -75.1% |
| 2008 | 1.64x | CN¥59.25 Million | CN¥36.03 Million | CN¥59.25 Million | ▲ +135.0% |
| 2007 | 0.70x | CN¥67.55 Million | CN¥96.53 Million | CN¥67.55 Million | ▲ +1.7% |
| 2006 | 0.69x | CN¥36.51 Million | CN¥53.05 Million | CN¥36.51 Million | — |